Legal Commentator
Leading Litigator
Lead Negotiator
Author

“Negotiated over $2.86 Billion in opioid harm reduction for the State of Texas ”

Jeffrey B. Simon Wins 'Best Attorney' Award 4 Years In A Row.

Jeffrey B. Simon is a commentator and founding partner of SIMON GREENSTONE PANATIER, PC. Ranked as one of the Top 10 Personal Injury Attorney's within America and Co-chair of the National Opioid Litigation Conference, Mr. Simon brings together medical, legal, and law experts to reduce the social and economic harms of the opioid pandemic.

Attorney Jeffrey B. Simon Secures $1.8 Billion Opioid Settlement for All Texans

Jeffrey B. Simon announced that he and a committee of trial lawyers, along with the Office of the Texas Attorney General, have reached a historic $1.8 billion settlement for Texas.

Texas reaches $290 million settlement with Johnson & Johnson

A $290 million settlement agreement Tuesday with pharmaceutical giant Johnson & Johnson over what the state claims were deceptive marketing tactics that contributed to the ongoing opioid crisis.

We're Suing Fossil Fuel Companies for $1.15 Billion

This industrially caused environmental disease will cause enormous harm, both in terms of human suffering...

social

Mitch’s Wife’s Chinese Travel Is Even Weirder Than We Knew @thedailybeast. Surely, there is a justifiable reason for Sec Chao’s world travel during her husband‘s serious illness. But, what is it? Please help me/U.S./Ky understand. #prayers #thoughts #help

U.S. & Iran exchange intense attacks after Trump says ceasefire is “over” @NBCNews. While destroying Iranian military sites feels good, it’s likely a fool’s errand. Iran knows Trump will eventually pay to rebuild them, open Strait & bring gas prices down.

Judge orders release of $5.8 million Trump owes E. Jean Carroll after court loss. While the harsh criticisms of #Platner and his political benefactors may be entirely deserved, let’s not lose sight that this #POTUS is no better, and perhaps worse. #facts

Load More

JEFFREY HAS BEEN FEATURED IN

In the news